M159 M159 Pill: white, capsule/oblong, 18mm
The pill with imprint M159 M159 (White, Capsule/Oblong, 18mm) has been identified as Didanosine Delayed Release 125 mg and is used for HIV Infection, and Nonoccupational Exposure. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for M159 M159
Didanosine Delayed Release
- Imprint
- M159 M159
- Strength
- 125 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-8886 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
carboxymethylcellulose sodium,
silicon dioxide,
diethyl phthalate,
gelatin,
hypromelloses,
methacrylic acid - methyl methacrylate copolymer (1:1),
propylene glycol,
shellac,
trisodium citrate dihydrate,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
potassium hydroxide,
ammonia
Note: Inactive ingredients may vary.
Related images for "M159 M159"
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.